KAYLA GESTRING: Open Payments
NPI 1558071969 · FENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 42 payments from 14 companies in 2025. Trend: 2023 $140 · 2024 $461 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $266 |
| AstraZeneca Pharmaceuticals LP | 6 | $108 |
| Lilly USA, LLC | 3 | $61 |
| Novo Nordisk Inc | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Edwards Lifesciences Corporation | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| PFIZER INC. | 2 | $35 |
| Exact Sciences Corporation | 1 | $21 |
Products named: QULIPTA, UBRELVY, VRAYLAR, AIRSUPRA, BREZTRI, JARDIANCE, Symbravo, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve.
Industry payments across MO — which companies pay providers there.
